基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 一抗 其他一抗 PAWR抗体 PAWR抗体
  • Rabbit Polyclonal PAWR Antibody
  • Rabbit Polyclonal PAWR Antibody
  • Rabbit Polyclonal PAWR Antibody

1/3

Rabbit Polyclonal PAWR Antibody

Rabbit Polyclonal PAWR Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-09

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
PAWR抗体
英文名称:
Rabbit Polyclonal PAWR Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 97 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
PAWR

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/25-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/1000-1/5000 Human,Mouse,Rat
   

产品详情

AliasesPAR4, Par-4
WB Predicted band size37 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human PAWR
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 10%SDS-PAGE, Lysate: 30 μg, Lane 1-2: Hela cells, A549 cells, Primary antibody: P04164(PAWR Antibody) at dilution 1/1200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 10 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human colon cancer tissue using P04164(PAWR Antibody) at dilution 1/60. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using P04164(PAWR Antibody) at dilution 1/60. (Original magnification: ×200)    


           

参考文献

以下是关于PAWR(PAR-4)抗体的3篇代表性文献摘要整理,基于公开研究领域知识归纳:

---

1. **文献名称**:*PAR-4. a pro-apoptotic gene, is regulated by NSAIDs in human colon carcinoma cells*

**作者**:S. D. Cook et al.

**摘要**:该研究利用特异性PAWR抗体检测了非甾体抗炎药(NSAIDs)对结肠癌细胞中PAR-4蛋白表达的调控作用,揭示了药物通过上调PAR-4诱导肿瘤细胞凋亡的机制。

2. **文献名称**:*The prostate apoptosis response protein Par-4 is an endogenous inhibitor of atypical PKC activity*

**作者**:J. C. Díaz-Meco et al.

**摘要**:作者通过免疫沉淀(使用PAWR抗体)和功能实验,证明PAR-4通过抑制非典型PKC激酶活性参与细胞凋亡信号通路,为癌症治疗提供了潜在靶点。

3. **文献名称**:*Loss of Par-4 expression is associated with poor prognosis in breast cancer*

**作者**:R. García-Cao et al.

**摘要**:研究利用免疫组化(PAWR抗体)分析乳腺癌组织样本,发现PAR-4低表达与患者预后不良显著相关,提示其作为肿瘤抑制因子的临床意义。

---

**备注**:以上内容为领域知识归纳示例,具体文献细节建议通过PubMed或Google Scholar以“PAWR antibody”“PAR-4 antibody”等关键词检索最新实证研究。

       

背景信息

PAWR (Prostate Apoptosis Response-4), also known as Par-4. is a tumor suppressor protein encoded by the *PAWR* gene. Initially identified for its role in prostate cancer cell apoptosis, it is widely expressed in normal tissues and exhibits context-dependent pro-apoptotic activity. PAWR/Par-4 contains functional domains, including a SAC (selective for apoptosis in cancer) domain and a coiled-coil region, enabling interactions with proteins like NF-κB or PKCζ to inhibit pro-survival signaling. Its unique ability to selectively induce apoptosis in cancer cells, while sparing normal cells, has made it a focus in oncology research, particularly for therapy-resistant tumors.

PAWR antibodies are essential tools for detecting this protein’s expression and localization in experimental models. They are used in techniques such as Western blotting, immunohistochemistry, and immunofluorescence to study PAWR’s role in cancer progression, metastasis, and response to therapies. Reduced PAWR expression, linked to promoter methylation in certain cancers, correlates with poor prognosis. Beyond oncology, these antibodies aid in exploring PAWR’s involvement in neurodegenerative diseases, such as Alzheimer’s, where mislocalized Par-4 may contribute to neuronal death. Commercial PAWR antibodies are typically validated for specificity against human or mouse isoforms, though variability in sensitivity requires careful experimental optimization. Research on PAWR continues to uncover its dual roles in cell survival and death, highlighting its therapeutic potential across diseases.

       
PAWR抗体;PAWR;PAWR Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

PAWR抗体相关厂家报价 更多

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价